Insider Transactions in Q2 2024 at Atea Pharmaceuticals, Inc. (AVIR)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2024
|
Bruce Polsky |
SELL
Open market or private sale
|
Direct |
17,544
-21.1%
|
$52,632
$3.49 P/Share
|
|
Jun 16
2024
|
Jerome M. Adams |
BUY
Exercise of conversion of derivative security
|
Direct |
33,150
+50.0%
|
-
|
|
Jun 16
2024
|
Barbara Gayle Duncan |
BUY
Exercise of conversion of derivative security
|
Direct |
33,150
+50.0%
|
-
|
|
Jun 16
2024
|
Bruce Polsky |
BUY
Exercise of conversion of derivative security
|
Direct |
33,150
+28.5%
|
-
|
|
Jun 16
2024
|
Franklin M Berger |
BUY
Exercise of conversion of derivative security
|
Direct |
33,150
+3.92%
|
-
|
|
Jun 16
2024
|
Bruno Lucidi |
BUY
Exercise of conversion of derivative security
|
Direct |
33,150
+28.5%
|
-
|
|
Jun 16
2024
|
Polly A. Murphy |
BUY
Exercise of conversion of derivative security
|
Direct |
33,150
+37.0%
|
-
|
|
Jun 05
2024
|
Jean Pierre Sommadossi President, CEO, and Chairman |
SELL
Open market or private sale
|
Indirect |
1,006
-0.02%
|
$4,024
$4.0 P/Share
|